Strides Pharma Science Limited has informed the Exchange that Board of Directors at its meeting held on May 18, 2026, recommended Final Dividend of Rs. 5 per equity share.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science Limited's Board of Directors, in its meeting held on May 18, 2026, has recommended a final dividend of Rs. 5 per equity share (50% dividend on face value of Rs. 10 each) for FY2026. The dividend is subject to shareholder approval at the ensuing Annual General Meeting and will be paid within 30 days of AGM approval after tax deduction. The record date to determine eligible shareholders will be fixed and intimated later. For context, the company reported consolidated revenue of Rs. 50,094 million and profit after tax of Rs. 5,745 million for FY2026, compared to Rs. 46,241 million and Rs. 4,094 million respectively in the previous year, showing robust growth. The statutory auditors issued an unmodified opinion on the financial results.
The recommendation of Rs. 5 per share dividend signals healthy financial performance and cash generation. Investors can expect regular income from this dividend, though the exact yield will depend on the prevailing stock price. The payment timeline and record date are yet to be announced.